Abstract: A chair has a supporting frame 1, a seat portion 101, a back portion 201 that has an upper end, a lower end, and is pivotally mounted relative to the supporting frame at a position above its lower end, and a recline mechanism 601. The recline mechanism 601 lifts the seat portion 101 upon a reclining action of the back portion 201, and has an operative connection 603, 611 between the seat portion and the supporting frame and a drag link 602 pivotally connected to the seat portion 101 and pivotally connected to the back portion 201 at a position below the pivotal mounting of the back portion relative to the supporting frame. As the back portion 201 of the chair is reclined, the lower end of the back portion 201 moves forward and the drag link 602 pulls the seat portion 101 upward relative to the supporting frame 1.

Abstract: A chair has a supporting frame 1, a seat portion 101, a back portion 201 that has an upper end, a lower end, and is pivotally mounted relative to the supporting frame at a position above its lower end, and a recline mechanism 601. The recline mechanism 601 lifts the seat portion 101 upon a reclining action of the back portion 201, and has an operative connection 603, 611 between the seat portion and the supporting frame and a drag link 602 pivotally connected to the seat portion 101 and pivotally connected to the back portion 201 at a position below the pivotal mounting of the back portion relative to the supporting frame. As the back portion 201 of the chair is reclined, the lower end of the back portion 201 moves forward and the drag link 602 pulls the seat portion 101 upward relative to the supporting frame 1.

Abstract: A chair has a supporting frame 1, a seat portion 101, a back portion 201 that has an upper end, a lower end, and is pivotally mounted relative to the supporting frame at a position above its lower end, and a recline mechanism 601. The recline mechanism 601 lifts the seat portion 101 upon a reclining action of the back portion 201, and has an operative connection 603, 611 between the seat portion and the supporting frame and a drag link 602 pivotally connected to the seat portion 101 and pivotally connected to the back portion 201 at a position below the pivotal mounting of the back portion relative to the supporting frame. As the back portion 201 of the chair is reclined, the lower end of the back portion 201 moves forward and the drag link 602 pulls the seat portion 101 upward relative to the supporting frame 1.

Abstract: The invention provides a housing adapted to provide for the juxtaposition of an oral hygiene device, such as a toothbrush, with an inhaler medication device, such as a metered dose inhaler (MDI) or dry powder inhaler (DPI). Also provided is an assembly including a housing, an oral hygiene device and an inhaler medication device wherein, in use, the housing and inhaler medication device together secure the oral hygiene device in the housing such that the oral hygiene device cannot be removed for use without first removing the inhaler medication device.

Abstract: A chair has a supporting frame 1, a seat portion 101, a back portion 201 that has an upper end, a lower end, and is pivotally mounted relative to the supporting frame at a position above its lower end, and a recline mechanism 601. The recline mechanism 601 lifts the seat portion 101 upon a reclining action of the back portion 201, and has an operative connection 603, 611 between the seat portion and the supporting frame and a drag link 602 pivotally connected to the seat portion 101 and pivotally connected to the back portion 201 at a position below the pivotal mounting of the back portion relative to the supporting frame. As the back portion 201 of the chair is reclined, the lower end of the back portion 201 moves forward and the drag link 602 pulls the seat portion 101 upward relative to the supporting frame 1.

Abstract: The invention provides a housing adapted to provide for the juxtaposition of an oral hygiene device, such as a toothbrush, with an inhaler medication device, such as a metered dose inhaler (MDI) or dry powder inhaler (DPI). Also provided is an assembly including a housing, an oral hygiene device and an inhaler medication device wherein, in use, the housing and inhaler medication device together secure the oral hygiene device in the housing such that the oral hygiene device cannot be removed for use without first removing the inhaler medication device.

Abstract: The disclosed system, device and method for molecular-scale electronic switching generally includes a carbon nanotube, an anode, a cathode and two conductive particles encapsulated within the carbon nanotube, wherein the particles are configured to move between high resistance and low resistance states. Disclosed features and specifications may be variously controlled, adapted or otherwise optionally modified to realize improved switching function.

Abstract: A chair includes a supporting frame and a seat portion which is foldable about a transverse fold to define a rearward portion behind the transverse fold and a forward portion, forward of the transverse fold. The seat portion is supported above the supporting frame by its rearward portion. The chair also includes a reclinable back portion and a recline mechanism with which the back portion is connected for reclining action of the back portion. The recline mechanism is operably linked to the rearward portion of the seat portion such that on reclining action of the back portion, the rearward portion is moved to increase in rearward tilt angle and to obtain a net increase in height above the supporting frame, with a consequent folding of the seat portion about the transverse fold line under the weight of the occupant.

Abstract: A chair includes a supporting frame and a seat portion which is foldable about a transverse fold to define a rearward portion behind the transverse fold and a forward portion, forward of the transverse fold. The seat portion is supported above the supporting frame by its rearward portion. The chair also includes a reclinable back portion and a recline mechanism with which the back portion is connected for reclining action of the back portion. The recline mechanism is operably linked to the rearward portion of the seat portion such that on reclining action of the back portion, the rearward portion is moved to increase in rearward tilt angle and to obtain a net increase in height above the supporting frame, with a consequent folding of the seat portion about the transverse fold line under the weight of the occupant.

Abstract: A chair includes a supporting frame and a seat portion which is foldable about a transverse fold to define a rearward portion behind the transverse fold and a forward portion, forward of the transverse fold. The seat portion is supported above the supporting frame by its rearward portion. The chair also includes a reclinable back portion and a recline mechanism with which the back portion is connected for reclining action of the back portion. The recline mechanism is operably linked to the rearward portion of the seat portion such that on reclining action of the back portion, the rearward portion is moved to increase in rearward tilt angle and to obtain a net increase in height above the supporting frame, with a consequent folding of the seat portion about the transverse fold line under the weight of the occupant.

Abstract: A cigar holder assembly is provided for golf carts utilizing biased clasps to hold one or more cigars in a vertical position over a removable ashtray. Temporary and permanent means for attaching the cigar holder to a golf cart are provided, and a swivel mount is provided between the attachment and the cigar holder to allow the cigar holder to maintain a substantially vertical orientation.

Abstract: The disclosed system, device and method for molecular-scale electronic switching generally includes a carbon nanotube, an anode, a cathode and two conductive particles encapsulated within the carbon nanotube, wherein the particles are configured to move between high resistance and low resistance states. Disclosed features and specifications may be variously controlled, adapted or otherwise optionally modified to realize improved switching function.

Abstract: A lancet driver is provided wherein the driver exerts a driving force on a lancet during a lancing cycle and is used on a tissue site. The driver comprises of a drive force generator for advancing the lancet along a path into the tissue site, and a sensor configured to detect lancet position along said path during the lancing cycle.

Abstract: A method is provided for controlling a lancet velocity profile. A velocity of a moving lancet is measured at a known position. The measured velocity of the lancet is compared with an appropriate velocity for the lancet at the known position. A force is applied to the lancet to adjust the velocity of the lancet.

Abstract: A sampling module includes a module body portion with a lancet channel, a lancet slidably disposed within the lancet channel. A cover sheet is disposed over the lancet and a lancet channel that captures the lancet shaft in the lancet channel, and a sample reservoir for collection of a sample obtained by lancing a patient with the lancet.

Abstract: A tissue penetration device includes a magnetic source that produces a controllable magnetic field in a magnetically active region adjacent the magnetic source. A magnetic member is disposed at least partially in the magnetically active region. A permanent magnet is disposed at a proximal end of the magnetically active region for zeroing the position of the magnetic member while the tissue penetration device is inactive.

Abstract: A method of lancing the tissue of a patient provides a tissue penetration element with a tip configured to penetrate tissue and a shaft portion. The tissue penetration element is disposed in proximity to the tissue of the patient. The tissue penetration element is driven distally towards the tissue of the patient. Contact is made between the tip and the tissue of the patient. The tip is advanced into the tissue during a penetration stroke to a position of maximum inward displacement. The tissue penetration element is allowed to settle upon reaching the point of maximum inward penetration for at least about 1 millisecond with no driving force imposed on the tissue penetration element. The tissue penetration element is displaced proximally over a withdrawal stroke and the tip is removed from the tissue.

Abstract: An agent injection device is provided that is capable of injecting an agent to a known predetermined tissue depth. An injection member has an elongate injection shaft with an outlet port configured to dispense an agent at a controllable time. A controllable driver is coupled to the elongate injection shaft and is configured to drive the injection member into target tissue. A velocity control system is in communication with the controllable driver and is configured to control the velocity of the elongate injection shaft.

Abstract: A moving coil tissue penetration device includes a magnetic source that produces a magnetic field in a magnetically active region. A cylindrical coil is secured to a translation substrate and disposed at least partially within the magnetically active region. A sharpened member is configured to penetrate tissue and mechanically coupled to the translation substrate.

Abstract: A method of lancing the tissue of a patient provides a tissue penetration element with a tip configured to penetrate tissue and a shaft portion. The tissue penetration element is disposed in proximity to the tissue of the patient. The tissue penetration element is driven distally towards the tissue of the patient. Contact is made between the tip and the tissue of the patient. The tip is advanced into the tissue during a penetration stroke to a position of maximum inward displacement. The tissue penetration element is displaced proximally over a withdrawal stroke at an average velocity that is substantially lower than an average velocity of the tissue penetration element during the penetration stroke. The tip is removed from the tissue.